➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: June 25, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for PF-04457845

Email this page to a colleague

« Back to Dashboard

What is the drug development status for PF-04457845?

PF-04457845 is an investigational drug.

There have been 9 clinical trials for PF-04457845. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2014.

The most common disease conditions in clinical trials are Osteoarthritis, Knee, Osteoarthritis, and Stress Disorders, Traumatic. The leading clinical trial sponsors are Pfizer, Yale University, and Tourette Association of America.

Recent Clinical Trials for PF-04457845
A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress DisorderPfizerPhase 2
FAAH Inhibitor Trial for Adults With Tourette SyndromeTourette Association of AmericaPhase 2
FAAH Inhibitor Trial for Adults With Tourette SyndromeYale UniversityPhase 2

See all PF-04457845 clinical trials

Clinical Trial Summary for PF-04457845

Top disease conditions for PF-04457845
Top clinical trial sponsors for PF-04457845

See all PF-04457845 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.